Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Retained Earnings / (Deficit)
Balance, beginning of period (in shares) at Jun. 30, 2023		18,280,000
Balance, beginning of period at Jun. 30, 2023	$ 149,964	$ 2	$ (3,682)	$ 204,734	$ (6,312)	$ (44,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,500					13,500
Foreign currency translation adjustments	(22)				(22)
Changes in fair value of cash flow hedges	201				201
Purchase of treasury shares (in shares)		(623,000)
Purchase of treasury shares	(10,434)		(10,434)
Provision for common stock warrants	594			594
Issuance of common shares (in shares)		24,000
Issuance of common shares	11			11
Share-based compensation expense	2,299			2,299
Balance, end of period (in shares) at Dec. 31, 2023		17,681,000
Balance, end of period at Dec. 31, 2023	156,113	$ 2	(14,116)	207,638	(6,133)	(31,278)
Balance, beginning of period (in shares) at Sep. 30, 2023		18,169,000
Balance, beginning of period at Sep. 30, 2023	156,039	$ 2	(5,726)	206,323	(7,207)	(37,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,075					6,075
Foreign currency translation adjustments	679				679
Changes in fair value of cash flow hedges	395				395
Purchase of treasury shares (in shares)		(489,000)
Purchase of treasury shares	(8,390)		(8,390)
Provision for common stock warrants	307			307
Issuance of common shares (in shares)		1,000
Issuance of common shares	6			6
Share-based compensation expense	1,002			1,002
Balance, end of period (in shares) at Dec. 31, 2023		17,681,000
Balance, end of period at Dec. 31, 2023	$ 156,113	$ 2	(14,116)	207,638	(6,133)	(31,278)
Balance, beginning of period (in shares) at Jun. 30, 2024	17,017,476	17,017,000
Balance, beginning of period at Jun. 30, 2024	$ 165,799	$ 2	(25,367)	210,200	(7,913)	(11,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	16,799					16,799
Foreign currency translation adjustments	477				477
Changes in fair value of cash flow hedges	186				186
Purchase of treasury shares (in shares)		(3,890,000)
Purchase of treasury shares	(76,240)	$ (1)	(76,239)
Issuance of common shares (in shares)		55,000
Issuance of common shares	725			725
Share-based compensation expense	$ 1,191			1,191
Balance, end of period (in shares) at Dec. 31, 2024	13,181,524	13,182,000
Balance, end of period at Dec. 31, 2024	$ 108,937	$ 1	(101,606)	212,116	(7,250)	5,676
Balance, beginning of period (in shares) at Sep. 30, 2024		16,765,000
Balance, beginning of period at Sep. 30, 2024	171,091	$ 2	(30,045)	210,872	(6,146)	(3,592)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,268					9,268
Foreign currency translation adjustments	(911)				(911)
Changes in fair value of cash flow hedges	(193)				(193)
Purchase of treasury shares (in shares)		(3,607,000)
Purchase of treasury shares	(71,562)	$ (1)	(71,561)
Issuance of common shares (in shares)		24,000
Issuance of common shares	343			343
Share-based compensation expense	$ 901			901
Balance, end of period (in shares) at Dec. 31, 2024	13,181,524	13,182,000
Balance, end of period at Dec. 31, 2024	$ 108,937	$ 1	$ (101,606)	$ 212,116	$ (7,250)	$ 5,676